A Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Topical Alicaforsen Enema in Subjects With Active, Chronic, Antibiotic Refractory Primary Idiopathic Pouchitis

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Topical Alicaforsen Enema in Subjects With Active, Chronic, Antibiotic Refractory Primary Idiopathic Pouchitis

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 29 Jun 2018

At a glance

  • Drugs Alicaforsen (Primary)
  • Indications Pouchitis
  • Focus Registrational; Therapeutic Use
  • Sponsors Atlantic Pharmaceuticals
  • Most Recent Events

    • 29 Jun 2018 According to an Atlantic Healthcare media release, St. Marks Hospital is one of the center for this trial.
    • 31 May 2018 This trial has been completed in Netherlands.
    • 02 May 2018 According to an Atlantic Healthcare media release, Prof. Brian Feagan, senior scientific director at Robarts clinical trials Inc. is a chief investigator on the study.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top